Back
Monte Rosa Therapeutics Stock Predictions
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Sell
11
GLUE
Monte Rosa Therapeutics
Last Price:
$7.07
Seasonality Move:
-3.94%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--hereMonte Rosa Therapeutics Stock Forecast
-
Over the next 52 weeks, Monte Rosa Therapeutics has on average historically fallen by 14.2% based on the past 3 years of stock performance.
-
Monte Rosa Therapeutics has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Monte Rosa Therapeutics Stock Undervalued?The current Monte Rosa Therapeutics [GLUE] share price is $7.05. The Score for GLUE is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
-
GLUE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Monte Rosa Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Monte Rosa Therapeutics has on average historically fallen by 14.2% based on the past 3 years of stock performance.
Monte Rosa Therapeutics Stock Rating
Sell
11
Monte Rosa Therapeutics (GLUE)
is a Sell
Is Monte Rosa Therapeutics overpriced?
-
Monte Rosa Therapeutics has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Monte Rosa Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
monterosatx.com
52-Week Data
52-Week High:
12.40
52-Week Low:
3.21
Prediction Charts
Market Cap:
433.1M
Price in USD:
7.05
Volume:
535.7K
Beta:
1.40
Technical Analysis
SMA50:
8.03
SMA100:
6.73
SMA200:
5.93
52-Wk Change:
22.82%
Stock Predictions
-
Is Monte Rosa Therapeutics stock public?Yes, Monte Rosa Therapeutics is a publicly traded company.
-
What is the Monte Rosa Therapeutics stock quote today?The Monte Rosa Therapeutics stock price is 7.05 USD today.
-
How to buy Monte Rosa Therapeutics stock online?You can buy Monte Rosa Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-5 | 9.16 | 8.83 | 9.60 | 8.80 |
| Dec-6 | 8.92 | 9.41 | 9.88 | 8.92 |
| Dec-9 | 9.57 | 10.20 | 10.21 | 9.40 |
| Dec-10 | 10.00 | 9.44 | 10.69 | 9.40 |
| Dec-11 | 9.34 | 8.51 | 9.84 | 8.50 |
| Dec-12 | 8.48 | 7.79 | 8.58 | 7.66 |
| Dec-13 | 7.87 | 7.56 | 8.24 | 7.50 |
| Dec-16 | 7.53 | 7.68 | 7.93 | 7.36 |
| Dec-17 | 7.62 | 7.67 | 7.95 | 7.52 |
| Dec-18 | 7.67 | 7.03 | 7.89 | 6.89 |
| Dec-19 | 6.81 | 6.51 | 6.83 | 6.15 |
| Dec-20 | 6.44 | 6.91 | 7.14 | 6.41 |
| Dec-23 | 6.90 | 7.14 | 7.22 | 6.89 |
| Dec-24 | 7.13 | 7.05 | 7.22 | 6.88 |
Monte Rosa Therapeutics Earnings
Monte Rosa Therapeutics Earnings Report: Per Share Monte Rosa Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Monte Rosa Therapeutics Forecast Revenue Growth
Monte Rosa Therapeutics Stock Analysis: Historical quarterly revenues per share for Monte Rosa Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.44 per share, and a decrease next year of $0.64 per share.
* Monte Rosa Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.